Huang, R., Hu, A., Rong, Q., Shu, D., Chen, M., Yang, W., . . . Shi, Y. Impacts of genomic alterations on the efficacy of HER2-targeted antibody–drug conjugates in patients with metastatic breast cancer. BMC.
Chicago Style (17th ed.) CitationHuang, Riqing, et al. Impacts of Genomic Alterations on the Efficacy of HER2-targeted Antibody–drug Conjugates in Patients with Metastatic Breast Cancer. BMC.
MLA (9th ed.) CitationHuang, Riqing, et al. Impacts of Genomic Alterations on the Efficacy of HER2-targeted Antibody–drug Conjugates in Patients with Metastatic Breast Cancer. BMC.
Warning: These citations may not always be 100% accurate.